Friday, December 9, 2016

Weekly Links December 9 , 2016



“MUST READ”
It is unfortunate that so many journalists begin with a narrative and then back fill the facts and points necessary to tell their narrative. via Pocket
TOOLS/TECHNIQUES
Say you’ve inherited a rare genetic mutation that guarantees you’ll get a certain form of cancer by the time you reach 50 years of age. And that this is most likely how you are going to die. via Pocket
The next generation has arrived, and with it, a clash of titans: Illumina, Thermo Fisher and Qiagen are all competing for the clinical market. Next-generation sequencing (NGS) companies are redefining DNA sequencing. via Pocket
HEALTH/MEDECINE
The objective of the French biotechnology company, Vect-Horus, is to leverage its technology, VECTrans, to facilitate the delivery of drugs into the brain and other organs. via Pocket
COMPANIES
Benchling, a biotech company out of Y Combinator providing cloud-based software for researchers, tells TechCrunch it has raised $7 million in growth funding to continue creating tools to help the science community access research from big pharma and…
Zymergen, a Bay Area startup creating all sorts of materials from genetically altered microbes, just raised $130 million in Series B funding from Softbank. For those unfamiliar, the company makes crazy new materials out of genetically altered microb…
SOMETHING DIFFERENT
As work itself is changing, some of the basic tenets of leadership development are being challenged. The very idea of leading people in jobs is changing with the democratization of work and the continued advance of digital technology. via Pocket

No comments:

Post a Comment